Home Cart Sign in  
Chemical Structure| 717847-03-5 Chemical Structure| 717847-03-5

Structure of 717847-03-5

Chemical Structure| 717847-03-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 717847-03-5 ]

CAS No. :717847-03-5
Formula : C8H12N4O
M.W : 180.21
SMILES Code : O1CCN(CC1)C2=CN=CC(=N2)N
MDL No. :MFCD05722015
InChI Key :PTQRJZXZMRXHBW-UHFFFAOYSA-N
Pubchem ID :45789813

Safety of [ 717847-03-5 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Computational Chemistry of [ 717847-03-5 ] Show Less

Physicochemical Properties

Num. heavy atoms 13
Num. arom. heavy atoms 6
Fraction Csp3 0.5
Num. rotatable bonds 1
Num. H-bond acceptors 3.0
Num. H-bond donors 1.0
Molar Refractivity 52.16
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

64.27 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.4
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-0.48
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-0.48
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.66
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.23
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.0

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.93
Solubility 21.2 mg/ml ; 0.117 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.4
Solubility 71.3 mg/ml ; 0.396 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.48
Solubility 5.99 mg/ml ; 0.0333 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.74 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.43

Application In Synthesis of [ 717847-03-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 717847-03-5 ]

[ 717847-03-5 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 110-91-8 ]
  • [ 33332-28-4 ]
  • [ 717847-03-5 ]
YieldReaction ConditionsOperation in experiment
at 100℃; for 22h; 6-Morpholinop razin-2-amineA stirred solution of 6-chloropyrazin-2-amine (0.225 g, 1.74 mmol) and morpho- line (0.227 g, 2.61 mmol) was heated at 100 °C for 22 h. After cooling to 23 °C, water was added to the mixture and extracted with EtOAc. The combined organics were concentrated in vacuo. The crude mixture was purified on alumina (0-50percent EtOAc in hexane) to give the desired product 6-morpholinopyrazin-2- amine. Mass Spectrum (ESI) m/e = 181.1 (M + 1).
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 717847-03-5 ]

Amines

Chemical Structure| 96225-80-8

A764495 [96225-80-8]

6-Morpholinopyrimidin-4-amine

Similarity: 0.65

Chemical Structure| 19943-95-4

A518246 [19943-95-4]

Imidazo[1,2-a]pyrazin-3-amine

Similarity: 0.63

Chemical Structure| 52023-68-4

A224552 [52023-68-4]

6-Morpholinopyridin-3-amine

Similarity: 0.59

Chemical Structure| 1370411-48-5

A233614 [1370411-48-5]

Pyrazine-2,6-diamine hydrochloride

Similarity: 0.58

Chemical Structure| 768386-37-4

A204194 [768386-37-4]

Pyrazine-2,5-diamine

Similarity: 0.57

Related Parent Nucleus of
[ 717847-03-5 ]

Morpholines

Chemical Structure| 96225-80-8

A764495 [96225-80-8]

6-Morpholinopyrimidin-4-amine

Similarity: 0.65

Chemical Structure| 40262-73-5

A289720 [40262-73-5]

6-(4-Morpholinyl)pyrazine-2-carboxylic acid

Similarity: 0.63

Chemical Structure| 52023-68-4

A224552 [52023-68-4]

6-Morpholinopyridin-3-amine

Similarity: 0.59

Chemical Structure| 848841-62-3

A129708 [848841-62-3]

4-(6-Bromopyrazin-2-yl)morpholine

Similarity: 0.55

Chemical Structure| 91233-71-5

A670785 [91233-71-5]

4-(Pyrimidin-5-yl)morpholine

Similarity: 0.54

Pyrazines

Chemical Structure| 40262-73-5

A289720 [40262-73-5]

6-(4-Morpholinyl)pyrazine-2-carboxylic acid

Similarity: 0.63

Chemical Structure| 1370411-48-5

A233614 [1370411-48-5]

Pyrazine-2,6-diamine hydrochloride

Similarity: 0.58

Chemical Structure| 768386-37-4

A204194 [768386-37-4]

Pyrazine-2,5-diamine

Similarity: 0.57

Chemical Structure| 446286-90-4

A193493 [446286-90-4]

2-Bromo-5-(piperazin-1-yl)pyrazine

Similarity: 0.56

Chemical Structure| 1001050-21-0

A159037 [1001050-21-0]

2-Bromo-5-(pyrrolidin-1-yl)pyrazine

Similarity: 0.56